These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36560591)

  • 1. Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A.
    Chathuranga WAG; Hewawaduge C; Nethmini NAN; Kim TH; Kim JH; Ahn YH; Yoon IJ; Yoo SS; Park JH; Lee JS
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Adjuvanticity of CAvant
    Ahn YH; Chathuranga WAG; Shim YJ; Haluwana DK; Kim EH; Yoon IJ; Lim YT; Shin SH; Jo H; Hwang SY; Kim HM; Lee MJ; Park JH; Yoo SS; Lee JS
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle.
    Li K; He Y; Wang L; Li P; Wang S; Sun P; Bao H; Cao Y; Liu X; Zhu G; Song Y; Bai X; Ma X; Fu Y; Yuan H; Zhang J; Wang J; Chen Y; Li D; Lou Z; Liu Z; Lu Z
    J Virol; 2021 Oct; 95(21):e0088121. PubMed ID: 34406868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.
    Hwang SY; Shin SH; Park SH; Lee MJ; Kim SM; Lee JS; Park JH
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
    Kim T; Hong JK; Oem JK; Lee KN; Lee HS; Kim YJ; Ryoo S; Ko YJ; Park JH; Choi J; Lee SH; Jo HJ; Lee MH; Kim B; Kim J
    Vaccine; 2019 Mar; 37(12):1702-1709. PubMed ID: 30712811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The High Immunity Induced by the Virus-Like Particles of Foot-and-Mouth Disease Virus Serotype O.
    Xiao Y; Zhang S; Yan H; Geng X; Wang Y; Xu X; Wang M; Zhang H; Huang B; Pang W; Yang M; Tian K
    Front Vet Sci; 2021; 8():633706. PubMed ID: 33718472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Vaccine; 2020 Jan; 38(5):1120-1128. PubMed ID: 31810782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
    Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
    Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
    Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a conformational neutralizing epitope on the VP1 protein of type A foot-and-mouth disease virus.
    Liu W; Yang B; Wang M; Wang H; Yang D; Ma W; Zhou G; Yu L
    Res Vet Sci; 2017 Dec; 115():374-381. PubMed ID: 28711695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O.
    Hwang SY; Shin SH; Kim HM; Shin S; Lee MJ; Kim SM; Lee JS; Park JH
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
    Liang W; Zhou G; Liu W; Yang B; Li C; Wang H; Yang D; Ma W; Yu L
    Arch Virol; 2016 Oct; 161(10):2705-16. PubMed ID: 27422396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.
    Xiao Y; Chen HY; Wang Y; Yin B; Lv C; Mo X; Yan H; Xuan Y; Huang Y; Pang W; Li X; Yuan YA; Tian K
    BMC Biotechnol; 2016 Jul; 16(1):56. PubMed ID: 27371162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.